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Objectives: This study aimed to determine the
prevalence of physical inactivity and perceived barriers
to physical activity among individuals with hypertrophic
cardiomyopathy (HCM), and to determine potential
demographic, clinical and health-related factors
influencing likelihood of meeting physical activity
guidelines.
Methods: This was a cross-sectional study of
consecutive patients (n=198) with HCM attending a
specialist HCM centre from July 2014 to November
2015. The primary outcome measure was physical
activity (minutes per day), as measured by self-report
(International Physical Activity Questionnaire (IPAQ))
and objective means (ActiGraph accelerometer). For
both, participants were classified as meeting guidelines
if they did at least 150 min per week of physical
activity. Quality of life (Short Form-36 V.2, SF-36v2),
barriers to exercise and clinical–demographic data were
also collected.
Results: In total, 54.8% of participants did not meet
physical activity recommendations based on IPAQ, and
12.7% did not meet guidelines based on accelerometer
data. The most commonly identified barriers to
exercise were ‘pain interferes with my exercise’ (33%)
and ‘I have an injury/disability that stops me’ (29%).
Independent factors associated with meeting guidelines
included older age (OR 0.66, 95% CI 0.51 to 0.85,
p=0.002), higher education level (OR 2.31, 95% CI
1.08 to 4.93, p=0.03), better physical quality of life
(OR 1.05, 95% CI 1.0 to 1.09, p=0.05) and more
reported barriers (OR 0.71, 95% CI 0.56 to 0.91,
p=0.01).
Conclusions: More than half of the patients with
HCM did not meet minimum physical activity
recommendations. Several barriers to exercise among
individuals with HCM exist, and provide the basis for
targeted interventions to promote physical activity and
improve overall health in patients with HCM.
INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is a
genetic heart disease with the hallmark
feature of left ventricular hypertrophy, which
confers an increased risk of arrhythmias and
sudden cardiac death.1 HCM is the most
common genetic heart disease with a preva-
lence of up to 1:200 in the general popula-
tion.2 HCM is inherited as an autosomal
dominant trait, with a 1 in 2 (50%) inherit-
ance risk to children.1 Consensus guidelines
recommend restricting individuals with HCM
from participating in physical activity of high-
intensity and/or a competitive nature,3 4 due
to the increased risk of sudden cardiac
arrest and death.5 Recommendations state
that patients with a genetic cardiovascular
disease, such as HCM, can safely participate
in activities of a low-to-moderate intensity;
however, no guidance is given as to the
recommended amount of physical activity to
be undertaken.3 With the focus often on
KEY QUESTIONS
What is already known about this subject?
▸ Very little is known about the physical activity
behaviours of individuals with hypertrophic car-
diomyopathy (HCM), and the barriers which
prevent them from doing sufficient physical
activity.
What does this study add?
▸ This study shows that many individuals with
HCM engage in insufficient physical activity, and
that there are particular barriers that should be
addressed so that these individuals may also
experience the benefits of regular physical
activity.
How might this impact on clinical practice?
▸ Individuals with HCM may be susceptible to low
physical activity levels. Physical activity is vital
for improving health and well-being for all indivi-
duals. For those with HCM, physical activity
should be encouraged with an emphasis on
what individuals can and should do, rather than
the small number of activities that are not
recommended. Personalised physical activity
recommendations, taking into account clinical
circumstances and identification of individual
barriers, will ultimately improve the specialised
care of patients with HCM.
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what activities individuals with HCM should avoid, the
need to undertake an appropriate level of physical activ-
ity may not be effectively communicated by clinicians,
potentially leading to inactivity and associated poor
general health.6
Physical activity has numerous health beneﬁts, includ-
ing prevention of non-communicable diseases such as
type 2 diabetes and cardiovascular disease, improvement
in mental health and well-being, and reductions in risk
of developing certain cancers and all-cause mortality.7–9
Physical inactivity is associated with poor health out-
comes, and is now the fourth leading cause of death
worldwide.10 In order to combat high rates of physical
inactivity, physical activity guidelines for adults (aged
18–64 years) have been developed in many countries,
which generally recommend being active on most (if
not all) days of the week and accumulating 150–300 min
of moderate-intensity physical activity or 75–150 min
of vigorous activity per week (or a combination of
both).11–13 Moderate activities include cycling, slow
jogging, doubles tennis and brisk walking.3 Individuals
with HCM report a reduction in physical activity follow-
ing diagnosis,14 and are known to report poor physical
health-related quality of life.15 Little is known about the
reasons for this reduction.
We hypothesised that individuals with HCM fail to
undertake sufﬁcient levels of physical activity, and there-
fore do not meet the minimum guideline recommenda-
tions. This study sought to establish the prevalence of
physical inactivity in a HCM cohort, to elucidate the bar-
riers to physical activity in this population and to deter-
mine potential demographic, clinical and health-related
factors inﬂuencing the likelihood of meeting physical
activity guidelines.
METHODS
Study design and participants
From July 2014 to November 2015, individuals with a
deﬁnite clinical diagnosis of HCM were recruited con-
secutively from the Hypertrophic Cardiomyopathy Clinic
at Royal Prince Alfred Hospital, Sydney, Australia.
Eligibility included a diagnosis prior to recruitment (ie,
those with a new diagnosis were excluded), aged
18 years or older, not pregnant and with sufﬁcient lan-
guage skills to complete the survey in English. Diagnosis
of HCM was made primarily based on presence of left
ventricular hypertrophy on echocardiogram of 15 mm
or greater (13–14 mm is considered borderline) in com-
bination with ECG abnormalities and archetypal clinical
features such as an apical systolic murmur.16
Individuals were invited to complete a written survey.
A subgroup of participants attending the clinic consecu-
tively from March 2015 to November 2015 were asked to
also wear an accelerometer for a minimum of 7 days.
The survey-only participants completed the survey at the
clinics, where possible, with some participants returning
their survey by post. Those participating in the
accelerometer substudy completed the survey after
wearing the accelerometer. The Sydney Local Health
District Ethics Review Committee approved the study,
and all participants gave informed written consent.
Clinical and demographic information
Clinical data were obtained from patient medical
records and included basic demographics: age, gender,
education and postcode (from which Socio-Economic
Indexes for Areas (SEIFA17) was determined); clinical
information including severity of left ventricular hyper-
trophy, New York Heart Association (NYHA) functional
class, existing comorbidities, family history of sudden
cardiac death and body mass index (BMI), and treat-
ments such as medications and implantable cardioverter
deﬁbrillator (ICD) therapy.
Survey assessments
International Physical Activity Questionnaire
The International Physical Activity Questionnaire (IPAQ)
is a widely used and validated measure for assessing phys-
ical activity among adults.18 This study used the self-
administered long form of the past 7 days recall version
of the IPAQ, which assesses frequency and duration of
walking, cycling, and other moderate-intensity and
vigorous-intensity physical activity across four activity
domains (work, transport, home, recreation). The IPAQ
guidelines for data management (http://www.ipaq.ki.se)
were followed. This study focused on self-reported time
spent in leisure-time physical activity (LTPA) only.
Participants were classiﬁed as meeting guidelines if they
engaged in ≥150 min/week of walking or other moderate
or vigorous physical activity (with duration of vigorous
activity multiplied by two), or ≥75 min or more per week
vigorous physical activity. This approach has been used
previously to examine physical activity behaviours during
leisure time, which are generally considered more discre-
tionary than other domains of activity.19
Medical Outcomes Survey Short Form-36 V.2
Quality of life was evaluated using the Short Form-36 V.2
(SF-36v2),15 20 21 a commonly used measure of
health-related quality of life that has been validated in
Australian populations.22 The survey provides scores
across eight domains of physical health and mental
health, including physical functioning, role limitations
due to physical health, bodily pain, general health, vitality,
social functioning, role limitations due to emotional
health and mental health. These scores are combined to
provide an overall estimate for physical health (physical
component score, PCS) and mental health (mental com-
ponent score, MCS). The survey was scored using the
QualityMetric Health Outcomes Scoring Software (V.4.5,
Lincoln, Rhode Island, USA). The subdomain scores
were compared with age-matched Australian population
norms (45–54 years).23 Weighted t-scores—standardised
as per Australian population norms—of physical (PCSAT)
and mental (MCSAT) health were also obtained.24
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Barriers to exercise
Participants were asked to select reasons they were not
being physically active from a list of 24 potential barriers
identiﬁed previously (see online supplementary appendix
1).25 26 The total number of barriers identiﬁed was deter-
mined in addition to the frequency at which individual
barriers were identiﬁed.
Physical activity accelerometer substudy
A subgroup of HCM individuals were also asked to wear
a hip-mounted ActiGraph GT3X+ accelerometer
(Pensacola, Florida, USA) on an elastic belt during all
waking hours except during water-based activities, such
as showering or swimming, for a period of 7 days. The
ActiGraph monitor records physical activity intensity
(activity counts per minute) which can be converted to
frequency and duration, and provides an objective
measure of overall physical activity in contrast to the
subjective domain-focused IPAQ survey. Acceleration
data were sampled by a 12-bit analogue-to-digital con-
verter at a rate of 30 Hz, and stored in non-volatile ﬂash
memory.27
On receipt of the monitors, the data were downloaded
and processed in 60 s epochs using the ActiLife software
(V.6.11.5). A valid day was deﬁned as a minimum of
10 hours recorded data (wear time), which excludes
times during which the monitor recorded at least 60
consecutive minutes of zero counts/minute (periods of
‘non-wear’).28 To be included in the analyses, partici-
pants needed to have a minimum of 3 days of valid wear
time.29 30 There was no signiﬁcant difference in amount
of moderate–vigorous physical activity performed on
weekend and weekdays (mean weekend day=35.6 min/
day, mean weekday=41.0 min/day, p=0.11); therefore, no
restriction on the minimum number of weekend or
weekdays was imposed in the criteria for inclusion in the
analysis. Age-speciﬁc cut points that are commonly used
in adult populations were selected to determine the
time (minutes) spent in light-intensity (100–2020
counts/minute), moderate-intensity (2021–5999 counts/
minute) and vigorous-intensity (≥6000 counts/minute)
physical activity.31 Moderate–vigorous physical activity
was calculated by summing time spent in moderate phys-
ical activity and vigorous physical activity. The durations
of bouts of activity at ≥2020 counts/minute (ie, at least
moderate activity) that spanned at least 10 consecutive
minutes were also computed and summed as a measure
of physical activity accumulated in sustained bouts.
Proportions of participants meeting the guideline
recommendations of 150 min or more moderate–vigor-
ous physical activity per week in sustained bouts of
10 min or more were calculated. For individuals with
<7 days valid wear, the total physical activity in bouts of
10 min was calculated by dividing the minutes per day of
physical activity (in bouts of 10 min or more) by the
number of valid days, and multiplying by seven to obtain
the estimated average per week.
Statistical analysis
Data were analysed using Stata V.14.1 (StataCorp).
Descriptive statistics were used to examine sociodemo-
graphic and clinical characteristics, physical activity (at
different intensities) for IPAQ and accelerometer data,
mental and physical health scores, and to determine the
most frequently identiﬁed barriers to exercise. Participants
who completed the accelerometer study were compared
with those who completed the survey only using χ2,
t-tests or Mann-Whitney tests, as appropriate, to ensure
that there were no signiﬁcant differences between the
two groups.
Logistic regression was used to identify factors asso-
ciated with meeting physical activity guidelines based on
IPAQ data (since these data were available for the whole
sample). Age was divided by 10 to demonstrate the
impact of a 10-year increase in age, rather than a single
year increase. Signiﬁcance was set at p≤0.05, correspond-
ing to a 95% CI. Univariate analyses were performed to
examine factors associated with the likelihood of partici-
pants meeting guidelines. Collinearity was tested
through calculation of variance inﬂation factors (VIFs)
between variables with p<0.1. All VIFs were <2; therefore,
no variables required exclusion. Variables associated with
meeting guidelines at p<0.1 in the univariate analysis
were included in a multivariate model, with a stepwise
backwards regression undertaken until only signiﬁcant
variables remained. The Bayesian Information Criterion
(BIC) was calculated as a guide of model ﬁt.
The individual barriers to exercise were assessed in




A total of 264 individuals with HCM were seen at the
clinics during the study period. Of these, 34 (12.9%)
were excluded due to insufﬁcient knowledge of English
(n=17), genotype-positive phenotype-negative (n=7) and
other reasons (eg, pregnancy, incorrect previous diagno-
sis; n=10). Of the 230 remaining eligible participants, 8
declined to participate, 23 withdrew from the study, and
one accelerometer and survey was lost in the post
leaving a total cohort of 198 individuals (ﬁgure 1).
There were no signiﬁcant age or gender differences
between the study cohort and those who declined to
participate or withdrew from the study.
The characteristics of the ﬁnal cohort of 198 HCM
participants are shown in table 1, with comparison
between the survey only (n=126) and accelerometer
subset (n=72). A signiﬁcant gender imbalance was
observed between groups (57.1% male survey partici-
pants vs 73.6% male accelerometer participants,
p=0.02). Additionally, a small difference in maximal wall
thickness was observed between survey and accelerom-
eter participants (p=0.04). The mean age was 48.8
±15.3 years. In the total HCM cohort, 39.4% had an ICD
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in situ, 50.0% were on β-blocker medication, 60.1% had
comorbidities and 24.0% were symptomatic based on
the NYHA class (>1). Comorbidities included respiratory
(eg, asthma and sleep apnoea), endocrine (eg, hyper-
thyroidism/hypothyroidism), cancer, muscular/skeletal
(eg, arthritis, joint replacement) and mental health con-
ditions. The most prevalent comorbidity was hyperten-
sion (n=41/196, 21%). Approximately a quarter (24.5%)
had documented non-sustained ventricular tachycardia
and 23% a history of syncope. A total of 32.8% had a
history of obstructive disease with a mean maximum
recorded gradient across the cohort of 40 mm Hg.
Seventeen individuals had had a surgical intervention
(alcohol septal ablation or myectomy) and atrial ﬁbrilla-
tion was reported in 21.2% of patients. Sixty-seven per
cent were classiﬁed as overweight or obese based on
BMI, and 55.1% came from an area of high socio-
economic status (SEIFA decile >8), with 34.6% having
tertiary education.
Levels of physical activity
A total of 186 participants (93.9%) had complete IPAQ
data for LTPA. The mean durations of activity at each
intensity are shown in table 2. The total mean time
spent in walking, moderate and vigorous LTPA was
∼3 hours/week. However, the median was 90.0 min/
week, and only 45.2% of the cohort met the minimum
Australian guidelines for physical activity with a bimodal
distribution observed (ﬁgure 2).
Accelerometer data were obtained from 69 individuals,
of whom 63 satisﬁed requirements for a minimum of
10 hours wear time on a minimum of 3 days. The
minutes per week in each activity were higher according
to accelerometry data than self-reported data, with a
mean of 4.6 hours/week of accelerometer-assessed mod-
erate–vigorous physical activity (table 2). When restricted
to activity undertaken in bouts of 10 min or more, the
mean moderate–vigorous physical activity was 55.5 min/
week, and only 12.7% (n=8) performed a minimum
Figure 1 Study recruitment flow chart. HCM, hypertrophic
cardiomyopathy.
Table 1 Clinical characteristics of study groups
Characteristic Total cohort Survey only Accelerometer subset p Value
Total HCM participants 198 126 72
Males, n (%) 125 (63.1%) 72 (57.1%) 53 (73.6%) 0.02*
Age (years), mean±SD 48.8±15.3 48.5±15.8 49.2±15.0 0.78
ICD in situ, n (%) 78/198 (39.4%) 54/126 (42.9%) 24/72 (33.3%) 0.19
On β-blockers, n (%) 97/194 (50.0%) 59/123 (48.0%) 38/71 (53.2%) 0.46
Comorbidities, n (%) 111/182 (61.0%) 67/116 (57.8%) 44/67 (65.7%) 0.32
NYHA (>1), n (%) 47/196 (24.0%) 29/125 (23.2%) 18/71 (25.4%) 0.73
Maximum LVH, mean±SD 22.5±6.4 23.2±0.6 21.2±0.7 0.04*
Documented NSVT, n (%) 47/192 (24.5%) 34/121 (28.1%) 13/71 (18.3%) 0.13
History of syncope, n (%) 40/177 (22.6) 30/115 (26.1%) 10/62 (16.2%) 0.13
History of LVOTO, n (%) 65/198 (32.8%) 38/126 (30.2%) 27/72 (37.5%) 0.29
Maximum gradient (mm Hg), mean±SD 39.8±3.7 36.3±4.4 46.2±6.8 0.21
Atrial fibrillation, n (%) 42/198 (21.2%) 31/126 (24.6%) 11/72 (15.3%) 0.12
Surgical intervention, n (%) 17/189 (9%) 9/121 (7.4%) 8/68 (11.8%) 0.32
Family history of SCD, n (%) 38/193 (19.7%) 27/122 (22.1%) 11/71 (15.5%) 0.26
BMI (kg/m2), mean±SD 27.6±5.2 27.5±5.4 27.7±5.0 0.76
Underweight (BMI<18.5) 2/194 (1.0%) 2/123 (1.6%) 0/71 (0.0%) NA
Normal (BMI 18.5–25) 62 (32.0%) 39 (31.7%) 23 (32.4%) 0.92
Overweight (BMI 25–30) 79 (40.7%) 50 (40.7%) 29 (40.8%) 0.98
Obese (BMI>30) 51 (26.3%) 32 (26.0%) 19 (26.8%) 0.91
SEIFA (>8), n (%) 109/198 (55.1%) 70/126 (55.6%) 39/72 (54.2%) 0.85
Tertiary educated, n (%) 65/188 (34.6%) 42/124 (33.9%) 23/64 (35.9%) 0.78
*p<0.05.
BMI, body mass index; ICD, implantable cardioverter defibrillator; HCM, hypertrophic cardiomyopathy; LVOTO, left ventricular outflow tract
obstruction; LVH, left ventricular wall hypertrophy; NA, not applicable; NSVT, non-sustained ventricular tachycardia; NYHA, New York Heart
Association functional classification; SCD, sudden cardiac death; SEIFA, Socio-Economic Indexes for Areas (ranked 1–10, higher score
indicates higher socioeconomic status).
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150 min/week (accrued in at least 10 min bouts) of mod-
erate–vigorous physical activity. Supplementary analyses
were conducted to rule out the possibility that the differ-
ences observed in the proportions meeting guidelines
according to IPAQ and accelerometry data were attribut-
able to differences between the samples. The proportions
of these two groups who met guidelines according to the
IPAQ were not signiﬁcantly different (41.5% vs 47.1%,
p=0.47). There was also no signiﬁcant difference between
mean minutes per week of LTPA between the accelerom-
eter participants and survey-only participants based on
self-report (169.4 vs 192.9 min, p=0.57).
Health-related quality of life (SF-36v2)
A total of 175 (88.4%) participants satisfactorily com-
pleted the SF-36v2. There were signiﬁcant differences
between the study cohort and age-matched Australian
norms observed in all domains excepting bodily pain
and social function (ﬁgure 3). The mean weighted
t-scores for physical health (PCSAT) and mental health
(MCSAT) were 45.9 (SD=10.6) and 45.6 (SD=13.4),
respectively. Australian-weighted t-scores correspond to a
population mean of 50 for the PCSAT and MCSAT, with
the majority of individuals falling within 1SD of the
mean (between 40 and 60). In the study cohort, 29.7%
(n=52) of participants had a PCSAT<40 and 26.3%
(n=46) of participants had a MCSAT <40.
Barriers to exercise
The most commonly identiﬁed barriers to exercise
included ‘pain interferes with my exercise’ (32.8%),
‘I have an injury/disability that stops me’ (29.3%) and
‘I don’t have time’ (27.9%; ﬁgure 4). There were 32
individuals (16.2%) who indicated they had been
advised not to exercise. The mean number of barriers
identiﬁed was 2.6±2.0 with a range of 0–9 barriers,
including 32 (16.2%) who identiﬁed 5 or more barriers
to exercise and 78 (39.4%) identifying 1–2 barriers each.
Factors and barriers associated with meeting physical
activity guidelines
A number of factors were found to be associated with
meeting guidelines in univariate analysis based on IPAQ
data (table 3). In multivariate analysis, age (adjusted OR
0.66, 95% CI 0.51 to 0.85, p=0.002), education (adjusted
OR 2.31, 95% CI 1.08 to 4.93, p=0.03), PCS (adjusted
OR 1.05, 95% CI 1.0 to 1.09, p=0.05) and identifying a
higher number of barriers (adjusted OR 0.71, 95% CI
0.56 to 0.91, p=0.01) were signiﬁcantly and independ-
ently associated with meeting physical activity guidelines
(table 3).
The sole barrier associated with a reduced likelihood
of meeting physical activity guidelines, when adjusted
for age, was poor health (adjusted OR 0.18, 95% CI 0.08
to 0.41, p=0.01; table 4).
DISCUSSION
When an individual is diagnosed with HCM, the recom-
mendation is to avoid vigorous exercise and competitive
sports due to the risk of sudden death. The response to






Light, min/week NA 1146.4±367.6 (361.7–1993.6)
Walking, min/week 107.7±199.9 (0–1260) NA
Moderate, min/week 44.0±102.6 (0.0–720.0) 272.4±137.7 (15.0–657.0)
Vigorous, min/week 36.0±95.1 (0.0–720.0) 11.6±20.8 (0.0–91.3)
MVPA, min/week 78.1±160.6 (0.0–1440.0) 284.0±146.9 (15.7–663.2)
MVPA (10 min bouts), min/week NA 55.5±75.8 (0.0–302.3)
MVPA+walking, min/week 184.7±267.3 (0.0–1505.0) NA
Physical activity guideline Participants meeting guideline (%)
150 min/week MVPA, LTPA including walking 84 (45.2%) –
150 min/week MVPA, in bouts of 10 min or more – 8 (12.7%)
IPAQ, International Physical Activity Questionnaire; LTPA, leisure-time physical activity; MVPA, moderate–vigorous physical activity; NA, not
applicable.
Figure 2 Distribution of physical activity (min/week) across
30 min increments. MVPA, moderate–vigorous physical
activity.
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these recommendations and how much physical activity
patients with HCM subsequently perform is poorly
understood. This study describes the physical activity
levels of individuals with HCM. Overall, 54.8% of this
cohort did not meet minimum guidelines for physical
activity. Older age and a higher number of perceived
barriers reduced the likelihood of meeting guidelines,
while better physical health-related quality of life and
having a tertiary education increased the likelihood of
meeting guidelines. The most critical barriers to not
meeting guidelines appeared to be health-related bar-
riers such as ‘my health isn’t good enough’ and ‘I have
an injury or disability that stops me’. Such barriers may
be particularly important for this population, and poten-
tially provide a basis for targeted interventions to
promote physical activity in individuals with HCM.
The physical health and mental health beneﬁts of
physical activity are well established; although studies
speciﬁcally in HCM are limited, there may be beneﬁts
speciﬁc to the disease that are as yet unconﬁrmed.14 For
example, preliminary studies in murine models of HCM
have shown that physical activity can prevent develop-
ment of ﬁbrosis and reverse aspects of HCM, such as
myocyte disarray.32 However, for individuals with HCM,
participation in competitive and vigorous-intensity
physical activity have historically been discouraged, with
disease management guidelines offering varying levels of
activity restrictions.3 4 This recommendation is based
largely on expert consensus that high-level exercise may
trigger arrhythmias and sudden death.5 Individuals with
HCM are informed of this recommendation at diagnosis
and many report an intentional decrease in physical
activity following diagnosis.14 Although the need to
undertake sufﬁcient low-intensity to moderate-intensity
physical activity is acknowledged in the consensus guide-
lines,3 individuals with HCM tend to focus only on what
they should not do rather than on what they should,
leading to a high prevalence of physical inactivity. In the
present study, 32 participants reported that they had
been advised not to exercise, potentially indicating poor
communication regarding the importance of perform-
ing an appropriate level of physical activity while avoid-
ing contraindicated activities.
In our current study, more than half did not meet the
minimum physical activity guidelines. Although the
IPAQ provides information across several domains, only
LTPA was used in this study as self-report physical activity
measures are known to have a propensity for overesti-
mation, and time spent in physical activity during leisure
time is indicative of healthy physical activity beha-
viours.19 Australian guidelines for physical activity recom-
mend brisk walking as an appropriate way to achieve
moderate physical activity; therefore, walking minutes
were included in our analyses. The intensity of walking is
not assessed by the IPAQ, and hence the proportion of
the sample meeting guidelines may be an overestimate if
some participants walked at a pace equivalent to less
than moderate intensity. The proportion of individuals
meeting physical activity guidelines based on IPAQ
results was similar to the general Australian adult popu-
lation (43%).33
Using an objective measure of physical activity, that
is, accelerometry, we showed an elevated mean moder-
ate–vigorous activity level compared with IPAQ results
Figure 3 Spider plot of the unstandardised SF-36v2
subscales, comparing our HCM population with the mean for
the general population (aged 45–54 years). Patients with HCM
scored significantly lower than the age-matched general AUS
population norms on the following subscales (marked with an
asterisk); PF (p<0.001), RP (p=0.004), GH (p<0.001), VT
(p=0.01), RE (p=0.01) and MH (p<0.001). BP and SF were
non-significant. AUS, Australian; BP, bodily pain; GH, general
health; HCM, hypertrophic cardiomyopathy; MH, mental
health; PF, physical functioning; RE, role emotional; RP, role
physical; SF, social function; SF-36v2, Short Form-36 V.2;
VT, vitality. *p<0.05.
Figure 4 Barriers to exercise identified by our HCM
population. HCM, hypertrophic cardiomyopathy.
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as it includes all activity across the whole week, not
solely LTPA, and also includes activity not necessarily
undertaken in bouts of at least 10 min. However, when
total activity accumulated in bouts of 10 min or more
was considered, that is, sustained physical activity, the
mean (55.5 min/week moderate–vigorous physical
activity) was well below the recommended 150 min,
and 87.3% of the individuals were not sufﬁciently
active.
Factors associated with a reduced likelihood of meeting
guidelines (based on IPAQ data) included older age,
lower education level (not tertiary) and identifying a
higher number of barriers. In contrast to previous
research indicating that individuals with a family history
Table 3 Factors associated with meeting physical activity guidelines
Unadjusted Adjusted (BIC=203.2)
OR (95% CI) p Value OR (95% CI) p Value
Clinical/sociodemographic
Age (years/10) 0.72 (0.59 to 0.88) 0.002* 0.66 (0.51 to 0.85) 0.002*
Gender
Female 1.13 (0.62 to 2.05) 0.69
Male 1.00 (reference)
BMI 0.92 (0.87 to 0.98) 0.01*
NYHA >1 0.52 (0.25 to 1.06) 0.07
=1 1.00 (reference)
Maximum LVH 1.01 (0.96 to 1.06) 0.71
Comorbidity Yes 0.69 (0.37 to 1.27) 0.23
ICD Yes 1.74 (0.96 to 3.15) 0.07
β-Blocker Yes 0.46 (0.25 to 0.84) 0.01*
FHx SCD Yes 1.00 (0.48 to 2.08) 0.99
Education Tertiary 2.22 (1.18 to 4.18) 0.01* 2.31 (1.08 to 4.93) 0.03*
Not tertiary 1.00
SEIFA ≥8 1.50 (0.84 to 2.70) 0.17
<8 1.00 (reference)
Quality of life
PCSAT 1.09 (1.05 to 1.13) <0.001* 1.05 (1.0 to 1.09) 0.05*
MCSAT 1.03 (1.00 to 1.06) 0.02*
Barriers
Number of barriers 0.67 (0.56 to 0.81) <0.001* 0.71 (0.56 to 0.91) 0.01*
*p<0.05.
BIC, Bayesian Information Criterion; BMI, body mass index; FHx SCD, family history of sudden cardiac death; ICD, implantable cardioverter
defibrillator; LVH, left ventricular wall hypertrophy; MCSAT, mental component, weighted t-score; NYHA, New York Heart Association
functional classification; PCSAT, physical component, weighted t-score; SEIFA, Socio-Economic Indexes for Areas (ranked 1–10, higher
score indicates higher socioeconomic status).
Table 4 Barriers associated with meeting physical activity guidelines
Unadjusted Adjusted (BIC=241.2)*
OR (95% CI) p Value OR (95% CI) p Value
Barrier to exercise†
I haven’t got time 1.25 (0.66 to 2.36) 0.50
My health isn’t good enough 0.16 (0.07 to 0.37) <0.001* 0.18 (0.08 to 0.41) 0.01*
I have an injury/disability 0.46 (0.24 to 0.89) 0.02*
Need to rest and relax 0.53 (0.22 to 1.29) 0.16
Young children to look after 3.20 (1.17 to 8.74) 0.02*
Too lazy/unmotivated 0.69 (0.34 to 1.39) 0.30
I haven’t got the energy 0.52 (0.26 to 1.05) 0.07
Pain interferes 0.61 (0.33 to 1.13) 0.12
Advised not to exercise 0.49 (0.21 to 1.15) 0.10
*p<0.05.
*Adjusted for age.
†Variables not included (n<5 in a cell)=‘There’s no one to do it with’, ‘I can’t afford it’, ‘I’m too old’, ‘I’m too shy/embarrassed’, ‘I’m not the
sporty type’, ‘There are no suitable facilities nearby’, ‘I might get injured or damage my health’, ‘I don’t enjoy physical activity’, ‘I haven’t got
the right clothes/equipment’, ‘I’d never keep it up’, ‘I’m too fat’, ‘other’, ‘I feel unsafe when active outdoors’, ‘I don’t know how or what to do’, ‘I
don’t know why I should exercise’.
BIC, Bayesian Information Criterion.
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of sudden cardiac death or those with an ICD have a
lower level of physical activity, these factors were not sig-
niﬁcantly associated with meeting guidelines in our
study.14 34 In addition to the clinical factors, having a ter-
tiary education was important, doubling the chances of
meeting guidelines. This is consistent with previous
studies, where low levels of education have been asso-
ciated with lower physical activity levels.35 Better physical
health-related or MH-related quality of life was associated
with increased likelihood of meeting guidelines.
However, consistent with previous studies of HCM popu-
lations,15 our results reveal lower physical and mental
quality of life when compared with the normal Australian
population. Given physical activity is known to improve
quality of life,36 increasing physical activity in the HCM
population may be an important factor in improving
health-related quality of life among this patient group.
Compared with previous studies in the general
Australian population, perceived barriers to exercise for
individuals with HCM were more likely health-related
rather than related to time or motivation. The most
commonly identiﬁed barriers in our study were ‘pain
interferes with my exercise’ and ‘I have an injury/dis-
ability that stops me’. In contrast, a study of physically
inactive Australians showed the most commonly identi-
ﬁed barriers were ‘I haven’t got time’ and ‘I’m too lazy/
not motivated/can’t get started’. Having an injury/dis-
ability was the third most common barrier reported
(pain was not listed as an option in this study).26 The
HCM individuals who identiﬁed poor health as a barrier
in our study were more likely to have a higher BMI, iden-
tify more barriers, have a higher NYHA class, report pres-
ence of comorbidities, be on β-blocker therapy, have
worse physical health-related and MH-related quality of
life, not be tertiary educated and live in an area of lower
socioeconomic status (see online supplementary table
S1). This suggests that these individuals truly have poorer
health and that this is a substantial barrier to achieving
adequate physical activity levels for this population.
In addition to health-related barriers, a number of
individuals highlighted barriers related to everyday life,
such as lack of time, and personal barriers such as being
unmotivated, not enjoying physical activity or not feeling
‘sporty’. Although health-related concerns, such as
disease symptoms (eg, breathlessness) or medication
side effects (ie, from β-blockers), may be difﬁcult to
overcome, these other life and personal barriers may be
more easily overcome with appropriate counselling and
encouragement. These results identify a promising
avenue for increasing physical activity in this population.
Study limitations
While we recruited consecutive patients attending a spe-
cialist HCM centre, the study was cross-sectional in
nature and therefore precludes inferences about causal-
ity. Owing to the nature of the barriers survey, it was not
possible to ascertain the details of the pain that people
indicated interfered with their physical activity. It is
feasible that individuals were referring to the potentially
uncomfortable nature of undertaking moderate physical
activity when not at a sufﬁcient level of ﬁtness, or may
refer to pain induced by arthritis or other muscular–
skeletal conditions.
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